Prevalence and predictors of elevated high-sensitivity C-reactive protein in post-myocardial infarction patients: Insights from the VIRGO and TRIUMPH registries-Reference-Cited by-同舟云学术

Prevalence and predictors of elevated high-sensitivity C-reactive protein in post-myocardial infarction patients: Insights from the VIRGO and TRIUMPH registries

Published:2017-12 Issue:12 Volume:40 Page:1205-1211
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Qintar Mohammed¹²^ORCID,Sharma Puza P.³,Pokharel Yashashwi¹²,Tang Yuanyuan¹,Lu Yuan⁴,Jones Philip¹²,Dreyer Rachel P.⁴,Spertus John A.¹²

Affiliation:

1. Department of Cardiology; Saint Luke's Mid America Heart Institute; Kansas City Missouri

2. Department of Cardiology; University of Missouri-Kansas City; Kansas City Missouri

3. Early Drug Development Department; Novartis Pharmaceuticals Corporation; East Hanover New Jersey

4. Department of Cardiology; Yale University; New Haven Connecticut

Funder

National Heart, Lung, and Blood Institute

CV Outcomes, Kansas City, Missouri

Novartis

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference29 articles.

1. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men;Ridker;N Engl J Med.,1997

2. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease;Sabatine;Circulation.,2007

3. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein;Ridker;N Engl J Med.,2008

4. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT;Bohula;Circulation,2015

5. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study;Bogaty;J Am Coll Cardiol.,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation Analysis of Acute Coronary Syndrome with Serum IL-18, MMP-9, hs-CRP, and Plasma FIB;BioMed Research International;2022-01-04

2. Comparison of high-sensitivity C-reactive protein vs. C-reactive protein for diagnostic accuracy and prediction of mortality in patients with acute myocardial infarction;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2021-03-28

3. Association of hs-CRP Levels and Medications Adherence Status among Heart Failure Patients at a Cardiac Referral Hospital in Tanzania;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2021

4. Association between temporal changes in C-reactive protein levels and prognosis in patients with previous myocardial infarction - A report from the CHART-2 Study;International Journal of Cardiology;2019-10

5. Relationship between high‐sensitivity C‐reactive protein and subclinical carotid atherosclerosis stratified by glucose metabolic status in Chinese adults;Clinical Cardiology;2018-12-10